Drew Watson
InvestorInvestor at DigitalDx Ventures
Find your path to Drew
119 people in our graph share verified history with Drew — schools, employers, funds. One of them is your warm intro.
About
Drew Watson works in biostatistics, machine learning, and personalized medicine. He founded Nephrosant, a molecular diagnostics company focused on kidney health, and advises companies in personalized medicine, diagnostics, and pharmaceutical development. His earlier oncology work included contributing to the development of Oncotype DX for breast cancer and diagnostic tests for several other cancers. Before entering diagnostics, he advised international companies on quality management under Dr. W. Edwards Deming. He holds a BS in Statistics from California State University East Bay, an MS in Statistical Computing from Stanford University, a PhD in Biostatistics from UCLA, and an MBA from Golden Gate University.
Invests in
AI & Machine LearningBiotechDigital HealthMedical Devices
Colleagues at DigitalDx Ventures
Frequently asked questions
- Who is Drew Watson?
- Drew Watson works in biostatistics, machine learning, and personalized medicine. He founded Nephrosant, a molecular diagnostics company focused on kidney health, and advises companies in personalized medicine, diagnostics, and pharmaceutical development. His earlier oncology work included contributing to the development of Oncotype DX for breast cancer and diagnostic tests for several other cancers. Before entering diagnostics, he advised international companies on quality management under Dr. W. Edwards Deming. He holds a BS in Statistics from California State University East Bay, an MS in Statistical Computing from Stanford University, a PhD in Biostatistics from UCLA, and an MBA from Golden Gate University.
- Where does Drew Watson work?
- Drew Watson is at DigitalDx Ventures.
- What does Drew Watson invest in?
- Drew Watson invests in AI & Machine Learning, Biotech, Digital Health, Medical Devices.